C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts

Transplantation

Volumn 86, Issue 12, 2008, Pages 1849-1856

  Torrealba, Jose R ^a,b,d   Samaniego, Milagros ^a   Pascual, Julio ^c   Becker, Yolanda ^a   Pirsch, John ^a   Sollinger, Hans ^a   Odorico, Jon ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Acute antibody mediated rejection; C4d; Pancreas allograft; Pathologic condition

Indexed keywords

C PEPTIDE; COMPLEMENT COMPONENT C4D; CORTICOSTEROID; IMMUNOGLOBULIN; INSULIN; PIOGLITAZONE; RITUXIMAB; THYMOCYTE ANTIBODY; ALLOANTIBODY; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; HLA ANTIGEN CLASS 1; HLA D ANTIGEN; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY MEDIATED REJECTION; ANTIBODY SPECIFICITY; ARTICLE; BIOPSY; CAPILLARY; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DONOR; ENDOTHELIUM; FEMALE; GRAFT REJECTION; HISTOLOGY; HUMAN; INSULIN TREATMENT; INTERSTITIUM; LYMPHOPROLIFERATIVE DISEASE; MALE; OUTCOME ASSESSMENT; PANCREAS TRANSPLANTATION; PARENCHYMA; PLASMAPHERESIS; PRIORITY JOURNAL; UNITED STATES; ACUTE DISEASE; ALLOTRANSPLANTATION; BLOOD; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MIDDLE AGED; PATHOLOGY;

ACUTE DISEASE; ADULT; BIOPSY; CAPILLARIES; COMPLEMENT C4B; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-D ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; PEPTIDE FRAGMENTS; TRANSPLANTATION, HOMOLOGOUS;

EID: 58849117189     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181902319     Document Type: Article

References (17)

1. Mauiyyedi S, Crespo M, Collins AB, et al. Acute humoral rejection in kidney transplantation. II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13: 779.
2. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708.
3. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753.
4. Melcher ML, Olson JL, Baxter-Lowe LA, et al. Antibody-mediated rejection of a pancreas allograft. Am J Transplant 2006; 6: 423.
5. Carbajal R, Karam G, Renaudin, et al. Specific humoral rejection of a pancreas allograft in the recipient of a pancreas after kidney transplantation. Nephrol Dial Transplant 2007; 22: 942.
6. Drachenberg CB, Papadimitriou JC, Klassen DK, et al. Evaluation of pancreas transplant needle biopsy: Reproducibility and revision of his-tologic grading system. Transplantation 1997; 63: 1579.
7. Drachenberg CB, Odorico J, Demetris AJ, et al. Banff schema for grading pancreas allograft rejection: Working proposal by a multi-disciplinary international consensus panel. Am J Transplant 2008; 8: 1237.
8. Pascual J, Samaniego MD, Torrealba JR, et al. Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol 2008; 19: 812.
9. Pelletier RP, Hennessy PK, Adams PW, et al. Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation. Am J Transplant 2002; 2: 134.
10. Secchi A, Di Carlo V, Martinenghi, et al. Effect of pancreas transplantation on life expectancy, kidney function and quality of life in uraemic type 1 (insulin dependent) diabetic patients. Diabetologia 1991; 34(suppl 1): S141.
11. Sudan D, Sudan R, Stratta R. Long-term outcome of simultaneous kidney-pancreas transplantation: Analysis of 61 patients with more than 5 years follow-up. Transplantation 2000; 69: 550.
12. Robertson RP, Davis C, Larsen J, et al. Pancreas and islet transplantation in type 1 diabetes. Diabetes Care 2006; 69: 550.
13. Andreoni KA, Brayman KL, Guidinguer MK, et al. Kidney and pancreas transplantationinthe United States, 1996-2005. Am J Transplant 2007; 7: 1359.
14. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US casesasreported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005; 19: 433.
15. Pirsch JD, Odorico JS, D'Alessandro AM, et al. Post-transplant infection in enteric versus bladder-drained simultaneous pancreas-kidney transplant recipients. Transplantation 1998; 66: 1746.
16. Odorico JS, Pirsch JD, Knechtle SJ, et al. A study comparing mycophenolate mophetil to azathioprine in simultaneous pancreas-kidney transplantation. Transplantation 1998; 66: 1751.
17. Colvin RB. Antibody-mediated renal allograft rejection. J Am Soc Nephrol 2007; 18: 1046.